Examination of aminophenol-containing compounds designed as antiproliferative agents and potential atypical retinoids
Open Access
- 24 February 2023
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 82, 117214
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The anti-tumor agent, p-DDAP potently suppresses proliferation through apoptosis in human neuroblastoma NB-39-nu cellsCancer Letters, 2010
- Retinoid pathway and cancer therapeuticsAdvanced Drug Delivery Reviews, 2010
- Effects of the Aminophenol Analogue p-Dodecylaminophenol on Mouse SkinJournal of Investigative Dermatology, 2010
- p‐Dodecylaminophenol derived from the synthetic retinoid, fenretinide: Antitumor efficacy in vitro and in vivo against human prostate cancer and mechanism of actionInternational Journal of Cancer, 2007
- Design of selective nuclear receptor modulators: RAR and RXR as a case studyNature Reviews Drug Discovery, 2007
- Potent anticancer activities of novel aminophenol analogues against various cancer cell linesBioorganic & Medicinal Chemistry, 2007
- Mechanisms of fenretinide-induced apoptosisApoptosis, 2006
- Anticancer and superoxide scavenging activities of p-alkylaminophenols having various length alkyl chainsBioorganic & Medicinal Chemistry, 2006
- Antioxidant Properties of N-(4-Hydroxyphenyl)retinamide (Fenretinide).Biological and Pharmaceutical Bulletin, 2000
- Effects of retinoid X receptor-selective ligands on profileration of prostate cancer cellsThe Prostate, 1997